Status:

COMPLETED

Effects of Vigiis 101-LAB on a Healthy Populations' Gut Microflora, Peristalsis, Immunity, and Anti-oxidative Capacity

Lead Sponsor:

SunWay Biotech Co., LTD.

Collaborating Sponsors:

National Taiwan University Hospital

Chung Shan Medical University

Conditions:

Gastrointestinal Microbiome

Eligibility:

All Genders

20-65 years

Phase:

NA

Brief Summary

Vigiis 101-LAB capsules I and II are produced from the fermentation of Lactobacillus paracasei subsp. paracasei NTU 101. Investigators have examined the effects of the Vigiis 101-LAB capsules I or II ...

Detailed Description

Detailed Description: 1.1 Lactobacillus paracasei subsp. paracasei NTU 101 strain (NTU 101) is a local Lactobacillus strain that was isolated and selected from the guts of newborns in Taiwan and show...

Eligibility Criteria

Inclusion

  • Healthy adults aged ≧ 20 years and ≦ 65 years.
  • Subjects with normal weight (body mass index: 18.5-24).
  • Subjects with no gastrointestinal diseases or on medication.

Exclusion

  • Pregnant or lactating women.
  • Subjects who are allergic to Lactobacillus.
  • Subjects with chronic gastrointestinal diseases.
  • Subjects who previously underwent gastrectomy or gastric bypass.
  • Subjects with liver, kidney, or heart disease, alcoholism, or uncontrolled diabetes.
  • Subjects who developed stroke, psychiatric diseases, or depression within the last 1 year.
  • Subjects being administered drugs that can regulate gastrointestinal function, functional foods, bacteriostatic drugs or supplements, antibiotics, antioxidants, or other unknown drugs within the last 2 weeks.
  • Patients who did not fulfill the inclusion criteria, did not administer the test product according to regulations, whose efficacy could not be determined, or who had incomplete data that affect efficacy or safety assessment.

Key Trial Info

Start Date :

March 27 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 20 2018

Estimated Enrollment :

54 Patients enrolled

Trial Details

Trial ID

NCT04046432

Start Date

March 27 2017

End Date

March 20 2018

Last Update

August 7 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine

Taipei, Taiwan, 104